Akebia Therapeutics
Chris Silva is an experienced professional in supply chain management, procurement, and sourcing, currently serving as Vice President at Akebia Therapeutics since 2018. In addition, Chris leads Petilliam Group as Managing Director, providing consulting services for life science clients. Previous roles include Head of Sourcing & Procurement at Synageva BioPharma Corp., where Chris implemented Oracle ERP and negotiated cost reductions, and Associate Director at Alkermes, PLC., focusing on procurement and supply chain processes. Chris's career began at Transkaryotic Therapies (TKT) as Associate Director of Global Supply Chain. Educational credentials include an Executive Certificate in Management and Leadership from MIT Sloan School of Management, an Executive Certificate in Leadership and Strategic Impact from The Tuck School of Business at Dartmouth, an MBA from Boston University, and a Bachelor's degree from Suffolk University with minors in Economics and Philosophy.
This person is not in any teams
This person is not in any offices
Akebia Therapeutics
3 followers
Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology.